| Trial ID: | L2340 |
| Source ID: | NCT00699426
|
| Associated Drug: |
Nexium
|
| Title: |
The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
|
| Acronym: |
Nexium
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: nexium|DRUG: nexium|DIETARY_SUPPLEMENT: Yoghurt|DRUG: placebo+placebo
|
| Outcome Measures: |
Primary: insulin secretion, 1 year | Secondary: blood pressure, 1 year
|
| Sponsor/Collaborators: |
Sponsor: Lise Tarnow | Collaborators: Novo Nordisk A/S|Chr Hansen|Statens Serum Institut|Steno Diabetes Center Copenhagen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
41
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-06
|
| Completion Date: |
2009-06
|
| Results First Posted: |
|
| Last Update Posted: |
2012-09-03
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00699426
|
